FDA issued a Warning Letter to Mylan Pharmaceuticals Inc. on 11/9/2018 for a previous inspection.
483 Mylan Pharmaceuticals Aug 2019

483 Mylan Pharmaceuticals Aug 2019

Katelyn Staub-Zamperini FDA$119.00 - Available Now

FDA investigators audited the Mylan Pharmaceuticals - Morgantown, WV, United States facility and issued inspectional observations (via FDA 483) on 15 Aug 2019.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 15 Aug 2019
  • Location: Morgantown, United States
  • FEI: 1110315
Add To Cart